Association between HLA-DM and HLA-DR in vivo

Immunity

Volumn 4, Issue 1, 1996, Pages 87-96

  Sanderson, Frances ^a   Thomas, Claire ^a   Neefjes, Jacques ^b   Trowsdale, John ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; CELL LINE; HLA SYSTEM; HUMAN; HUMAN CELL; MUTANT; PH; PRIORITY JOURNAL;

EID: 0030021969     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80301-5     Document Type: Article

References (42)

1. Adams, T.E., Bodmer, J.G., and Bodmer, W.F. (1983). Production and characterization of monoclonal antibodies recognizing the α-chain subunits of human la alloantigens. Immunology 50, 613-624.
2. Anderson, M.S., and Miller, J. (1992). Invariant chain can function as a chaperone protein for major histocompatability complex molecules. Proc. Natl. Acad. Sci. USA 89, 2282-2286.
3. Avva, R.R., and Cresswell, P. (1994). In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1, 763-774.
4. Bakke, O., and Dobberstein, B. (1990). MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716.
5. Castellino, F., and Germain, R.N. (1995). Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2, 73-88.
6. Cresswell, P. (1994). Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.
7. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82, 155-165.
8. Denzin, L.K., Robbins, N.F., Carboy-Newcomb, C., and Cresswell, P. (1994). Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1, 595-606.
9. Fling, S.P., Arp, B., and Pious, D. (1994). HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368, 554-558.
10. Germain, R.N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
11. Karlsson, L., Peleraux, A., Lindstedt, R., Liljedahl, M., and Peterson, P.A. (1994). Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266, 1569-1573.
12. Kelly, A.P., Monaco, J.J., Cho, S., and Trowsdale, J. (1991). A new human HLA class II-related locus, DM. Nature 353, 571-573.
13. Koppelman, B., and Cresswell, P. (1990). Rapid nonlysosomal degradation of assembled HLA class II glycoproteins incorporating a mutant DR α-chain. J. Immunol. 145, 2730-2736.
14. Lamb, C.A., and Cresswell, P. (1992). Assembly and transport properties on invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148, 3478-3482.
15. Lampson, L.A., and Levy, R. (1980).Two populations of la-like molecules on a human B cell line. J. Immunol. 125, 293-299.
16. Lotteau, V., Teyton, L., Peleraux, A., Nilsson. T., Karlsson, L., Schmid, S.L., Quranta, V., and Peterson, P.A. (1990). Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.
17. Maric, M.A., Taylor, M.D., and Blum, J.S. (1994). Endosomal aspartic proteinases are required for invariant chain processing. Proc. Natl. Acad. Sci. USA 91, 2171-2175.
18. Marks, M.S., Blum, J.S., and Cresswell, P. (1990). Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with the HLA class II antigens. J. Cell Biol. 111, 839-856.
19. Mellins, E., Smith, L., Arp, B., Cotner, T., Celis, E., and Pious, D. (1990). Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 343, 71-74.
20. Mellins, E., Kempin, S., Smith, L., Monji, T., and Pious, D. (1991). A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J. Exp. Med. 174, 1607-1615.
21. Mellins, E., Cameron, P., Amaya, M., Goodman, S., Pious, D., Smith, L., and Arp, B. (1994). A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J. Exp. Med. 179, 541-549.
22. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J., and Mellins, E. (1994). An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-554.
23. Neefjes, J.J., Stollorz, V., Peters, P.J., Geuze, H.J., and Ploegh, H.L. (1990). The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61, 171-183.
24. Peters, P.J., Neefjes, J.J., Oorschot, V., Ploegh, H.L., and Geuze, H.J. (1991). Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349, 669-676.
25. Peterson, M., and Miller, J. (1990). Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345, 172-174.
26. Pious, D., Dixon, L., Levine, F., Cotner, T., and Johnson, R. (1985). HLA class II regulation and structure: analysis with HLA-DR3 and HLA-DP point mutants. J. Exp Med 162, 1193-1207.
27. Qiu, Y., Xu, X., Wandinger-Ness, A., Dalke, D.P., and Pierce, S.K. (1994). Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125, 595-605.
28. Quaranta, V., Majdic, O., Stingl, G., Liszka, K., Honigsmann, H., and Knapp, W. (1984). A human la cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). J. Immunol. 132, 1900-1905.
29. Riberdy, J.M., and Cresswell, P. (1992). The antigen processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. J. Immunol. 148, 2586-2590.
30. Riberdy, J.M., Newcomb, J.R., Surnam, M.J., Barbosa, J.A., and Cresswell, P. (1992). HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360, 474-477.
31. Roche, P.A., and Cresswell, P. (1990). Invariant chain association with DR molecules inhibits immunogenic peptide binding. Nature 345, 615-618.
32. Roche, P.A., and Cresswell, P. (1991). Proteolysis of class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA 88, 3150-3154.
33. Roche, P.A., Marks, M.S., and Cresswell, P. (1991). Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 345, 392-394.
34. Roche, P.A., Teletski, C.L., Karp, D.R., Pinet, V., Bakke, O., and Long, E.O. (1992). Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J. 11, 2841-2847.
35. Sanderson, F., Kleijmeer, M.J., Kelly, A.P., Verwoerd, D., Tulp, A., Neefjes, J.J., Geuze, H.J., and Trowsdale, J. (1994). Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266, 1566-1569.
36. Sette, A., Ceman, S., Kubo, R.T., Sakaguchi, K., Apella, E., Hunt, D.F., Davis, T.A., Michel, H., Shabanowitz, J., Rudersdorf, R., Grey, H.M., and DeMars, R. (1992). Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258, 1801-1804.
37. Sherman, M.A., Weber, D.A., and Jensen, P.E. (1995). DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197-205.
38. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802-806.
39. Stam, N.J., Spits, H., and Ploegh, H.L. (1986). Monoclonal antibodies raised against HLA-B locus H-chain permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137, 2299-2306.
40. Stern, L., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
41. Teyton, L., O'Sullivan, D., Dickson, P.W., Lotteau, V., Sette, A., Fink, P., and Peterson, P.A. (1990). Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348, 39-44.
42. Wraight, C.J., van Endert, P., Moller, P., Lipp, J., Ling, N.R., McLennan, I.C.M., Koch, N., and Moldenhauer, G. (1990). Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J. Biol. Chem. 265, 5787.